v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (37,320) $ (47,177)
Adjustments to reconcile net loss to cash flows (used in) provided by operating activities:    
Depreciation and amortization of property and equipment 7,757 6,770
Amortization of intangible assets 22,795 26,297
Amortization of debt issuance costs and original issue discount 1,401 3,445
Amortization of accumulated other comprehensive gain related to interest rate swap   (8,196)
Stock-based compensation 8,775 8,016
Deferred income taxes (8,984) (8,104)
Change in fair value of warrant liability (1,641) 875
Change in fair value of preferred stock liability   8,091
Dividends accrued on preferred stock liability   2,743
Payment of dividends accrued on preferred stock liability   (6,686)
Foreign currency exchange losses 587 2,023
Changes in operating assets and liabilities:    
Accounts receivable 4,578 56,146
Inventory (2,820) (4,405)
Other operating assets (186) 8,854
Accounts payable 5,083 (20,541)
Accrued expenses and other long-term liabilities (11,030) (8,407)
Deferred revenue 6,675 (16,422)
Net cash (used in) provided by operating activities (4,330) 3,322
Cash flows from investing activities:    
Purchases of property and equipment (17,831) (5,613)
Purchases of software licenses   (263)
Net cash used in investing activities (17,831) (5,876)
Cash flows from financing activities:    
Borrowings under revolving line of credit   44,106
Principal payments on revolving line of credit   (44,106)
Proceeds from issuance of term debt   342,300
Principal payments of term debt (1,750) (235,395)
Payment of debt issuance costs   (3,978)
Payment of preferred stock liability   (56,850)
Proceeds from the exercise of stock options 6 17
Payment of tax obligations related to vested stock awards and units (3,396) (2,638)
Repurchase of common stock (2,253)  
Net cash (used in) provided by financing activities (7,393) 43,456
Effect of exchange rate changes on cash and cash equivalents 1,349 (124)
Net (decrease) increase in cash and cash equivalents (28,205) 40,778
Cash, cash equivalents and restricted cash, beginning of year 90,479 26,630
Cash, cash equivalents and restricted cash, end of period 62,274 67,408
Supplemental disclosure of cash flow information:    
Interest paid 19,167 12,222
Income taxes paid 7,716 9,664
Income tax refunds received 474 991
Supplemental disclosure of non-cash investing activities:    
Capital expenditures incurred, but not yet paid 5,436 1,786
Inventory transfers to property and equipment 874 954
Supplemental disclosure of non-cash financing activities:    
Warrant liability released to additional paid-in-capital 150  
Fair value of vested restricted and performance-based stock grants $ 11,253 $ 9,095